atezolizumab,oxaliplatin,5-fluorouracil,l-leucovorin,bevacizumab,irinotecan
roche
['crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'atezo', 'atezotribe', 'bev/']
 phii rand atezotribe update of 8c folfoxiri/bev/atezo (med pfs 13.1, os 33.0 mos) vs folfoxiri/bev (pfs 11.5, 27.2 mos) in unselected #1l mcrc but mostly r-sided/ras mt w/ic &amp; tmb high predictive pfs/os benefit w/atezo arm in pmmr cohort #asco23 
Medical oncologist and researcher in gastrointestinal and genitourinary cancers @CedarsSinai. Hematology/Oncology fellowship @cityofhope